Close Menu

Big Pharma Needs Luck

Deepak Singh at bbgm ponders an article he read in the Financial Times that pairs drug discovery and serendipity. There is a role for serendipity in drug discovery, but the declining productivity of the pharma industry is not necessarily due to lazy scientists who can't innovate, he says. Systems biology is tough -- and managing and understanding all the data from these experiments is no easy task.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

President Donald Trump might not approve the stricter standards the US Food and Drug Administration is developing for authorizing a SARS-CoV-2 vaccine, according to Politico.

Wired reports that Oxitec has now developed a genetically modified fall armyworm.

A large genetic study finds SARS-CoV-2 viruses with a certain variant are spreading more than others, according to the Washington Post.

In Nature this week: sister-chromatid-sensitive chromosome conformation capture approach, and more.